Between 2021 and 2022, the Blood Grouping Reagents Market Size Value Per Capita in Poland remained stable at 0.6 Percent US Dollars Per Capita, indicating no year-on-year variation. This stability follows a period of slight growth from 2018 to 2020. The Compound Annual Growth Rate (CAGR) over the last five years (2018-2022) reveals a modest increase of approximately 1.03%, reflecting gradual market growth amidst varying healthcare demands and technological advancements in diagnostic methodologies.
Looking ahead, future trends in the Blood Grouping Reagents Market in Poland may be influenced by several factors, including advancements in genotyping technologies, increased awareness of transfusion-transmitted diseases, and the growing importance of personalized medicine. The integration of automated systems and AI for blood testing could also play a significant role in shaping the market. As healthcare continues to evolve, these developments are likely to drive further growth and innovation within the sector.
| # | 13 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 2.14 | 2023 | View data | ||
| 2 | 2 United Kingdom | 1.64 | 2023 | View data | ||
| 3 | 3 Italy | 1.52 | 2023 | View data | ||
| 4 | 4 Greece | 1.35 | 2023 | View data | ||
| 5 | 5 Croatia | 1.01 | 2023 | View data | ||
| 7 | 7 Hungary | 0.84 | 2023 | View data | ||
| 8 | 8 Belgium | 0.65 | 2023 | View data | ||
| 9 | 9 Poland | 0.59 | 2023 | |||
| 10 | 10 Lithuania | 0.48 | 2023 | View data | ||
| 11 | 11 Australia | 0.36 | 2023 | View data | ||
